Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1931 - 1940 of 2525

  • Reshaping a department through research, innovation, and advocacy: A conversation with Deborah Driscoll

    Driscoll has been chair of Penn’s Department of Obstetrics and Gynecology since 2005. She is widely recognized as a transformative leader and one of the world's leading obstetrician-gynecologist geneticists, specializing in the care of women with genetic disorders. She is also the director of Penn’s Center for Research on Reproduction & Women’s Health and the March of Dimes Prematurity Research Center.

    FULL STORY AT Penn Medicine News →

  • Tailoring lactation education to the cultural needs of Orthodox Jewish families

    Breastfeeding is an accepted practice for millions of women worldwide and strongly endorsed by the World Health Organization. To provide appropriate counseling about human milk and breastfeeding, it is important to understand cultural beliefs and customs related to the practice.

    FULL STORY AT Penn Nursing News →

  • PARP inhibitors can shrink tumors in pancreatic cancer patients with specific mutations

    Using a PARP inhibitor as maintenance therapy could provide a less toxic option for patients. Treatment either shrunk tumors or stopped them from growing in 17 of 19 patients in an interim analysis from a trial at the Abramson Cancer Center.

    FULL STORY AT Penn Medicine News →

  • Learning to lead and leading to learn: Penn GSE alumni as senior leaders at Penn

     Five “homgrown” senior leaders at Penn draw upon expertise they acquired in Penn GSE’s Higher Education division to achieve professional success and make an impact on the nation’s higher education landscape.

    FULL STORY AT Graduate School of Education →

  • Targeted drug for leukemia tested at Penn Medicine helps patients live longer

    Researchers at the Abramson Cancer Center found that an inhibitor drug that targets a specific mutation in relapsed or refractory acute myeloid leukemia helps patients live almost twice as long as those who receive chemotherapy. 

    FULL STORY AT Penn Medicine News →

  • CD40 combination therapy can shrink pancreatic tumors

    A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients. The early findings provide hope that this strategy involving a CD40 antibody, a checkpoint inhibitor, and standard-of-care chemotherapy could be effective treatment.

    FULL STORY AT Penn Medicine News →

  • Doctors more likely to prescribe preventive therapy when prompted by EMR extension

    A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.

    FULL STORY AT Penn Medicine News →

  • Doctors more likely to prescribe preventive therapy when prompted by EMR extension

    A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.

    FULL STORY AT Penn Medicine News →

  • Philosophy of race

    Quayshawn Spencer, Robert S. Blank Presidential Associate Professor of Philosophy, explores the question, “What kind of thing is race?” in his classes and research. (Audio)

    FULL STORY AT OMNIA →

  • Collective consciousness

    Lorena Levano, a graduate student in the College of Liberal and Professional Studies, uses collective social behavior to address sexual harassment and online grooming.

    FULL STORY AT OMNIA →